Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
DoJ Copaxone Kickback Suit ‘Flawed’ And An ‘Overreach,’ Teva Says
Teva Has Filed Motion To Dismiss FCA Complaint
Oct 22 2020
•
By
Dean Rudge
'The government...does not allege that any physician was influenced to prescribe Copaxone, or any patient to use it, because of these donations,' Teva argues • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin